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Abstract
Background: Rickettsia spp. (Rickettsiales: Rickettsiaceae) are Gram-negative, obligate intracellular, a-proteobacteria that
have historically been associated with blood-feeding arthropods. Certain species cause typhus and spotted fevers in
humans, but others are of uncertain pathogenicity or may be strict arthropod endosymbionts. Genetic manipulation of
rickettsiae should facilitate a better understanding of their interactions with hosts.
Methodology/Principal Findings: We transformed a species never associated with human disease, Rickettsia montanensis,
by electroporation with a TN5 transposon (pMOD700) containing green fluorescent protein (GFPuv) and chloramphenicol
acetyltransferase (CAT) genes under regulation of promoters cloned from the Rickettsia rickettsii ompB gene, and isolated a
Chloramphenicol-resistant GFP-fluorescent rickettsiae population (Rmontanensis700). The Rmontanensis700 rickettsiae
contained a single transposon integrated near an acetyl-CoA acetyltransferase gene in the rickettsial chromosome. Northern
blots showed that GFPuv and CAT mRNAs were both expressed as two transcripts of larger and smaller than predicted
length. Western immunoblots showed that Rmontanensis700 and E. coli transformed with a plasmid containing the
pMOD700 transposon both expressed GFPuv proteins of the predicted molecular weight.
Conclusions/Significance: Long-standing barriers to transformation of rickettsiae have been overcome by development of
transposon-based rickettsial transformation vectors. The ompB promoter may be the most problematic of the four
promoters so far employed in those vectors.
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Introduction
The genus Rickettsia (Rickettsiales: Rickettsiaceae) consists of
small, obligately intracellular Gram-negative bacteria that have
been studied principally as established and newly emerging human
pathogens transmitted by specific blood-feeding arthropods [1,2].
That historical view of rickettsiae as essentially a group of vector-
borne pathogens of humans has yielded to a new appreciation of
the genus as a group of bacterial endosymbionts that are widely
distributed in a diverse range of arthropods and other inverte-
brates and even protozoa and plants [3,4]. Nevertheless, the
majority of known Rickettsia spp. are associated with arthropods
and in some cases function as reproductive manipulators of their
hosts [5,6]. The close and apparently ancient relationship of the
genus Rickettsia with arthropods is consistent with the probable
evolution of vertebrate-pathogenic rickettsiae from nonpathogenic
ancestors [4,7].
Rickettsiae that are widely distributed in North American ticks
that readily feed on humans but are not associated with human
disease include the recently isolated (TJ Kurtti, unpublished) Ixodes
scapularis endosymbiont [8,9,10], Rickettsia peacockii and R. mon-
tanensis. R. peacockii was isolated from Dermacentor andersoni collected
in Montana [11] and Colorado [12], occurs at high prevalence
in D. andersoni and Dermacentor variabilis tick populations in the
northwestern USA and western Canada [13,14]. R. peacockii is not
pathogenic in laboratory animals and may be a limiting factor
in the incidence of Rocky Mountain Spotted Fever (RMSF)
by interfering with transovarial transmission of R. rickettsii
in Dermacentor ticks [15,16]. R. montanensis was isolated from D.
andersoni and D. variabilis ticks collected in Montana [17], was
originally described as R. montana [18], and is widely distributed
in Dermacentor tick populations in the northern and eastern
USA [17,19,20,21,22,23,24]. R. montanensis is not pathogenic in
laboratory animals [25,26,27,28]. Similar to R. peacockii, R.
montanensis may affect the epidemiology of Rocky Mountain
spotted fever by interference with transovarial transmission of R.
rickettsii infections in ticks [15,16,29], and by conference of
protective immunity to infected mammalian hosts subsequently
exposed to R. rickettsii [25,26]. Recent studies have begun to
explore the dynamics of the D. variabilis gene expression response
to infection with R. montanensis [30,31,32], which is perhaps the
best established laboratory model for study of the interactions of a
Dermacentor tick host with a spotted fever group Rickettsia spp. that is
not a human pathogen.
The study and comparative analysis of nonpathogenic Rickettsia
spp.withtheirpathogeniccongenersmayilluminatethemechanisms
of rickettsial pathogenesis. The nonpathogenic Rickettsia spp. are
attractive targets for development of transformation technologies
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transformation of pathogenic rickettsiae. Until recently, transforma-
tion of rickettsiae was frustrated by lack of appropriate selectable
markers and a reliable transformation system [33]. Those barriers
are now yielding to change in recommended drug treatments for
rickettsiosis patients [34,35,36] and development of TN5 and
Himar1 transposon vectors for transformation of rickettsiae.
Transformation with a TN5 transposon carrying a rifampicin
resistance factor gene under regulation of the Rickettsia prowazekii rpsL
promoter allowed isolation of gene knockout mutants of R. prowazekii
[37,38]. TN5 transposomes were also used to transform Rickettsia
monacencis to express chloramphenicol acetyltransferase resistance
factor (CAT) and green fluorescent protein (GFPuv) genes under
regulation of ompA promoters cloned from Rickettsia rickettsii [39,40].
Northern blot and RT-PCR analyses demonstrated expression of
mRNA transcripts of the expected lengths but TN5-mediated
transformation of R. monacensis with a GC-rich gene encoding the
DsRed2 fluorescent reporter under regulation of the powerful R.
rickettsii ompB promoter resulted in expression of two unexpected
mRNA species that were not translated [39]. R. prowazekii was
subsequently transformed with a Himar1 transposon that carried
rifampin resistance and GFPuv expression cassettes derived from the
above transposon vectors as well as a Himar1 transposase gene
under regulation of the Borrelia flg promoter [41].
The successful transposon-based transformations of typhus
group (R. prowazekii) and spotted fever group (R. monacensis)
rickettsiae implied general applicability to other rickettsiae. To
validate that concept and to further evaluate the utility of the ompB
promoter, we chose R. montanensis as a target for transformation
with a TN5 transposon carrying genes encoding the CAT and
GFPuv markers under regulation of independent ompB promoters.
We obtained Chloramphenicol-resistant R. montanensis transfor-
mants that expressed GFPuv from a single chromosomally
integrated transposon, but they were substantially less fluorescent
than the R. monacensis GFPuv transformant. Northern blot analyses
indicated that both genes were expressed as two transcripts of
unpredicted length as in the case of ompB promoter regulated
expression of DsRed2 transcripts in R. monacensis. However,
Western blot analyses demonstrated expression of GFPuv protein
of the predicted molecular mass of 26 kDa in contrast to lack of
DsRed2 protein expression in R. monacensis. The results confirmed
utility of the recently developed transposon-based rickettsial
transformation technologies, but indicated the need for careful
evaluation of the existing and candidate promoters that may be
utilized in further development of rickettsial transformation
vectors. The Rmontanensis700 transformant can be used to
enhance the R. montanensis in D. variabilis model system through
visualization of GFP-fluorescent rickettsiae in unfixed tick tissues.
Materials and Methods
Growth, Purification and Transformation of Rickettsiae
Rickettsia montanensis isolate M5/6 [17] and Rickettsia monacensis
isolate IrR/Munich[42] weregrown intheI. scapularis ISE6 cellline
[43] maintained in L-15B300 medium as described previously [43].
Rickettsiae were released from infected host cells suspended in L-
15B300 medium by aspiration (5 times) through a bent 27 gauge
hypodermic needle attached to a 5 ml syringe. The host cell lysates
were passed through a 2.7 mm pore size syringe filter to remove
cellular debris, and the filtrates were centrifuged at 15,0006g at 4uC
for 5 min to collect rickettsiae. The rickettsiae were resuspended
and transformed by electroporation with the pMOD700 transposon
or used to prepare genomic DNA as described previously [39].
Transformant R. montanensis were isolated and maintained under
Chloramphenicol (CHL) (Roche, Indianapolis, IL) as described
previously [39].
The pMOD700 Transposon Vector
The pMOD700 transposonvector wasconstructedwith the same
materials and methods used in construction of the closely related
pMOD658 and pMOD601 rickettsial transformation vectors as
described previously [39]. All enzymes and other reagents were
from Invitrogen (Rockville, MD) or Promega (Madison, WI) and
were used according to manufacturers’ recommendations. In brief,
expression cassettes containing the CAT and GFPuv genes under
regulation of the R. rickettsii isolate Hlp#2 ompB gene promoter and
ompA gene transcriptional terminator were assembled and inserted
into the pMOD-2,MCS. transposon construction vector (Epi-
centre, Madison, WI) to obtain the pMODompBCAT\GFPuv700
(pMOD700) rickettsial transformation vector. Transposons were
released from the vector and used to prepare transposomes for
electroporation of rickettsiae according to the manufacturer’s
suggested protocol.
Rickettsial Genomic DNA Preparation and Southern Blot
Analyses
Rickettsial genomic DNA was prepared from resuspended
rickettsiae as described previously [39]. For Southern blots, 100 ng
rickettsial DNA was digested overnight with Hind III, MunI or
PstI at 37uC, electrophoresed on1% agarose/TAE gels, trans-
ferred onto positively charged nylon membrane and hybridized
with digoxigenin-labelled CAT and GFPuv gene probes as
described previously [39].
Characterization of the Transposon Integration Site
The pMOD700 transposon integrated into the R. montanensis
genome was recovered by plasmid rescue cloning of the CAT
gene. XhoI-digested and EcoR1-digested DNA from transformant
R. montanensis cells was treated with the DNA Terminator
R End
Repair Kit, ligated into the pSMART-LCKan vector with Clone
Smart DNA ligase and electroporated into E. cloni
TM 10 G
electrocompetent cells according to the manufacturer’s suggested
protocols (Lucigen, Madison, WI). Electroporated cells were
plated on Luria-Bertani agarose plates containing 50 mg per ml
of CHL. Resistant colonies growing at 37uC were cultured in LB
medium with 50 mg per ml of CHL. LCKan plasmid DNA
bearing the rescued pMOD700 transposon was prepared from
resistant cultures with the High Pure Plasmid Isolation Kit
(Roche). Rickettsial DNA flanking the pMOD700 transposon was
sequenced (ABI 377 automated sequencer - Advanced Genetic
Analysis Center, University of Minnesota) using the pMOD SqRP
and SqFP primers and the LCKan vector SL1 and SR1 primers.
RT-PCR and Northern Blot Detection of CAT and GFPuv
mRNAs
RNA was prepared from bacteria with the RiboPure Kit
(Ambion, Austin, TX) according to the manufacturer’s protocol,
including Dnase I treatment. Fifty ng aliquots of RNA were used
as template in Access RT-PCR System (Promega) reactions
according to the manufacturer’s protocol with CAT and GFPuv
gene primers as described previously [39]. A second round RT-
PCR reaction was executed with a nested GFPuv gene primer
pair: TTCTGTCAGTGGAGAGGGTGAAGGTGATGC and
CCATTCTTTTGTTTGTCTGCCGTG. The reaction products
were electrophoresed in 1% agarose/TAE gels and stained
with EtBr or SYBR Green (Molecular Probes, Eugene, OR) for
UV visualization. For Northern blots, RNA was prepared from
Rickettsia GFPuv Expression
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from RNeasy kit spin columns according to the manufacturer’s
protocols (Qiagen, Valencia, CA). RNA was electrophoresed on
1% agarose/formaldehyde gels in 1x MOPS running buffer,
transferred onto positively charged nylon membrane and hybrid-
ized with digoxigenin-labelled CAT and GFPuv probes as
described previously [39].
Western Immunoblot Analysis of GFPuv Expression
Expression of GFPuv protein was analyzed by Western
immunoblotting. Bacteria were boiled in 2 volumes of Tris buffer-
2%SDS-660 mM b-mercaptoethanol-bromophenol blue tracking
dye. Protein concentration in the extracts was determined with
a Bradford Protein Assay kit (Bio-Rad, Hercules, CA). Proteins
(10 mg) were separated by electrophoresis in a GeneMate Express
mini-SDS-polyacrylamide gradient gel (8 to 16%; ISC BioExpress,
Kaysville, UT) and blotted onto Immobilon-P membranes (Milli-
pore, Bedford, MA). GFP-specific bands were detected with goat
anti-GFP IgG (Rockland Immunochemicals, Gilbersville, PA) as
described previously [39].
Visualization of GFP-Fluorescent Rickettsiae
Tick ISE6 cells or DVE1 cells derived from D. variabilis [44]
were infected with transformant R. montanensis and spun onto
microscope slides using a Cytospin centrifuge (Shandon Southern
Instruments, Sewickly, PA). The GFP-fluorescent rickettsiae were
visualized on a Nikon C1 Imaging Confocal Microscope equipped
with a GFP filter and digital imaging system at the University of
Minnesota, College of Biological Sciences, Imaging Center.
Results
Structure of the pMOD700 Rickettsial Transformation
Vector
The pMODompBCAT\GFPuv700 (pMOD700) vector was
constructed from the same PCR-amplified R. rickettsii ompB
promoter and ompA terminator transcriptional regulatory ele-
ments, and the GFPuv and CAT genes that were used to construct
the pMOD658 and pMOD601 rickettsial transformation vectors
[39]. The pMOD700 vector, depicted schematically in Fig. 1, has
independent GFPuv and CAT gene expression cassettes, each with
an ompB promoter and ompA terminator, arranged in tandem head
to tail orientation within the transposon. The overall structure of
the pMOD700 vector therefore resembled that of the pMOD658
vector in which the genes were under regulation of ompA
promoters and terminators [39]. In the pMOD601 vector, a
DsRed2 reporter gene under regulation of the ompB promoter was
placed in opposite head to tail orientation to the CAT gene under
regulation of the ompA promoter, with a single ompA terminator
located between the 39 ends of the CAT and DsRed2 genes [39].
Isolation and Visualization of Transformant R.
montanensis
Rickettsiae, electroporated with pMOD700 transposomes and
inoculated onto ISE6 cells, were selected with CHL at 2 ug per ml
with biweekly medium changes. Extracellular rickettsiae were
no longer visible after several days but by 3 months after
electroporation, several small, discrete plaques were noted in the
cell layer. At that time, CHL was temporarily withdrawn, and two
days later, the culture was fully infected. Control rickettsiae did not
survive CHL selection. The CHL-resistant rickettsiae were
designated as R. montanensis pMODompBCAT\GFPuv line 700
(Rmontanensis700) and were serially passed by inoculation of
0.1 ml of infected culture onto new ISE6 cell cultures maintained
with 1 ug of CHL per ml and are currently at the 29
th passage.
Although the Rmontanensis700 rickettsiae were resistant to
CHL, GFPuv-fluorescent rickettsiae were difficult to visualize on a
Nikon Eclipse E400 microscope equipped with epifluorescent
illumination and a fluorescein isothiocyanate filter. In contrast, the
GFPuv-fluorescent Rmona658 transformant rickettsiae [39] were
easily visualized on the same microscope. However, the Rmonta-
nensis700 rickettsiae were clearly GFPuv-fluorescent when
examined on a confocal microscope equipped with a more
sensitive digital camera. Fluorescent rickettsiae were visible in
ISE6 cells and in DVE1 cells (Fig. 2) as widely dispersed single and
diplococcal bacteria (arrowheads) and as dense clusters (arrow)
that increased in size as the infection progressed.
Determination of the pMOD700 Transposon Integration
Site in the R. montanensis Chromosome
We confirmed integration of the pMOD700 transposon in the
R. montanensis chromosome by Southern blot analysis. Rickettsial
DNA extracts were electrophoresed in a 1% agarose gel and
transferred onto a nylon membrane. The pMOD700 plasmid
digested with XhoI, which cleaves once within the GFPuv gene
(Fig. 1), hybridized with a CAT gene probe as the expected single
band migrating at approximately 4.6 kbp (Fig. 3, lane 2) relative to
DNA size markers (lane 1). Untransformed R. montanensis DNA
digested with HindIII, which cleaves near the 39 end of the ompB
promoters in the pMOD700 transposon (Fig. 1), did not hybridize
with the CAT probe (Fig. 3, lane 3). Rmontanensis700 DNA
digested with HindIII hybridized to the CAT probe as a single
band migrating at approximately 1.3 kbp (lane 4), consistent with
integration of a single pMOD700 transposon approximately
0.5 kbp from a HindIII site in the rickettsial chromosome.
Integration of a single transposon was confirmed by hybridization
of Rmontanensis700 DNA digested with PstI and MunI, which
respectively cleave once near the 59 end of the transposon and
within the GFPuv gene (Fig. 1). We observed a single PstI-digested
band that migrated at approximately 9 kbp (lane 5) and a
predominant MunI-digested band at approximately 2.3 kbp as
well as a very faint larger band probably due to incomplete
digestion (lane 6), consistent with integration of the transposon
approximately 1 kbp from an MunI site in the rickettsial
chromosome.
We identified the pMOD700 transposon insertion site by
sequencing the CHL marker-rescued transposon and flanking R.
montanensis DNA. All rescued clones contained a single copy of the
transposon with intact mosaic element sequences at each end that
were flanked by the 9-bp insertion site sequence duplications
typical of EZ::TN transposase. All clones contained the same 9-bp
duplication (ATTTTATGG), indicating that the Rmontanen-
sis700 transformant population was derived from a single
transposon integration event. The sequence data revealed the
presence of HindIII and MunI sites located approximately 0.5 and
1 kbp, respectively from the CAT terminal end of the integrated
transposon, consistent with the Southern blot data (see above).
BLAST alignment of the R. montanensis sequences flanking the
integrated transposon to the R. conorii genome (Genbank accession
no. AE006914) showed that the transposon had integrated within
a sequence that was highly similar to that of a R. conorii gene
(RC1133) encoding a predicted protein of unknown function. The
9 bp insertion site duplication at the transposon ends correspond-
ed to nucleotide positions 1,048,051–1,048,059 in the R. conorii
genome. The nearby R. conorii split gene (RC1134 and RC1135)
that encoded an acetyl-CoA acetyltransferase was also present on
Rickettsia GFPuv Expression
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similar split gene.
GFPuv and CAT mRNA Expression in Transformant R.
montanensis
We used reverse transcriptase polymerase chain reactions (RT-
PCR) and Northern blot assays to assess CAT and GFPuv mRNA
expression under regulation of the ompB promoter. RT-PCR
reactions with RNA extract from Rmontanensis700 yielded the
predicted 399 bp product with nested GFPuv primers (Fig. 4A,
lane 5), but control reactions without reverse transcriptase (lanes
4), without RNA (lane 2) or with untransformed R. montanensis
RNA (lane 3) did not. Likewise, RT-PCR reactions with RNA
extracted from Rmontanensis700 yielded the predicted 650 bp
product with CAT primers (Fig. 4B, lane 5), but control reactions
without reverse transcriptase (lane 6), without RNA (lane 2) or
with untransformed R. montanensis RNA with (lane 3) or without
reverse transcriptase (lane 4) did not. The results confirmed
expression of GFPuv and CAT mRNAs in the Rmontanensis700
transformant.
We used Northern blots to further characterize the expression
profiles of the GFPuv and CAT genes in Rmontanensis700.
Rickettsial RNA extracts were electrophoresed in 1% agarose
formaldehyde gels and stained with EtBr. Intact ribosomal RNA
migrated as bands at approximately 1.6 and 3.8 kb relative to
RNA markers (Fig. 5A, lane 1) in RNA extracts of untransformed
R. montanensis (lanes 2 and 5) and Rmontanensis700 (lanes 3 and 6).
The RNAs were transferred from the gel onto nylon membranes
for hybridization with GFPuv and CAT gene probes. We
predicted a minimum length 920 nucleotide GFPuv mRNA
transcript based on the predicted ompB promoter transcription
start site and untranslated mRNA sequence [45] as well as
transcription of 70 nucleotides of the ompA terminator to form
mRNA hairpin structures and stop transcription [46]. Similarly,
we predicted an 860 nucleotide CAT mRNA transcript. The
Northern blots showed that the GFPuv and CAT probes did not
Figure 1. The pMODompBCAT\GFPuv700 transformation vector. Relative positions of the following functional elements are indicated: the 19
nucleotide mosaic element (ME) sites recognized by EZ::TN Transposase; the rickettsial ompB promoters (BProm) and ompA transcription terminators
(ATer); the green fluorescent protein (GFPuv), chloramphenicol acetyltransferase (CAT) and ampicillin resistance (AMP) genes with direction of
transcription indicated by arrow heads. Lines indicate restriction enzyme sites involved in Southern blot experiments, plasmid rescue cloning, and
excision of the transposon from the vector for incubation with EZ::TN transposase to form transposomes for electroporation.
doi:10.1371/journal.pone.0008965.g001
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respectively). The GFPuv probe hybridized to unexpected 1,200
and 600 nucleotide transcripts in Rmontanensis700 RNA extracts
(lane 3). Similarly, the CAT probe hybridized to unexpected 1,400
and less abundant 700 nucleotide transcripts in Rmontanensis700
RNA extracts (lane 6). The results showed that the GFPuv and
CAT genes in the Rmontanensis700 transformant were both
expressed under regulation of the ompB promoter as two
transcripts that were longer and shorter than the predicted lengths.
GFPuv Protein Expression in Transformant R. montanensis
Because the Rmontanensis700 transformant produced unex-
pected GFPuv mRNA transcripts and it was less fluorescent than
the Rmona658 transformant that produced the expected GFPuv
mRNA transcript [39], we used Western immunoblots to study
expression of the GFPuv protein. No protein in untransformed R.
montanensis control extracts (Fig. 6, lane 4) was recognized by a
polyclonal anti-GFP antibody but extracts of Rmontanensis700
(lane 3) and E. coli transformed with pMOD700 plasmid (lane2)
contained proteins that recognized by the antibody as major bands
that co-migrated at the predicted GFPuv molecular mass of
26 kDa relative to marker protein bands (lanes 1 and 5). The
results indicated that Rmontanensis700 and E. coli expressed a
predominant GFPuv protein species of the predicted molecular
mass despite the expression of both larger and smaller than
expected GFPuv mRNA transcripts in Rmontanensis700 (Fig. 5B,
lane 3).
Figure 2. GFPuv-fluorescent R. montanensis transformant cells in tick DVE1 cells. Arrow indicates dense cluster of fluorescent rickettsiae
and arrowheads indicate dispersed single (left) and diplococcal (right) rickettsiae. Scale bar indicates 10 mm. Inset at upper right approximately 2.5x
zoom.
doi:10.1371/journal.pone.0008965.g002
Figure 3. Southern blot detection of the pMOD700 transposon
CAT gene in DNA of the Rmontanensis700 transformant. Lane 1:
contained a 1 kbp-DNA marker ladder with relative migration positions
indicated at left. Lane 2: 10 picograms of pMOD700 plasmid digested
with XhoI. Lane 3: 100 nanograms of untransformed R. montanensis
genomic DNA digested with HindIII. Lanes 4, 5 and 6 contained 100
nanograms of transformant Rmontanensis700 DNA digested with
HindIII, PstI and MunI, respectively. The blot was hybridized with a
CAT gene probe.
doi:10.1371/journal.pone.0008965.g003
Figure 4. Detection of GFPuv and CAT mRNAs in Rmontanen-
sis700 RNA extracts by RT-PCR. (A) RT-PCR analysis with GFPuv
primers. Lane 1: 100-bp DNA marker ladder with sizes indicated at left.
RT-PCR reactions were: no RNA control (lane 2); untransformed R.
montanensis RNA (lane 3); Rmontanensis700 RNA without (lane 4) and
with (lane 5) reverse transcriptase. (B) RT-PCR analysis with CAT primers.
Lane 1 as above. RT-PCR reactions were: no RNA control (lane 2);
untransformed R. montanensis RNA with (lane 3) and without (lane 4)
reverse transcriptase; Rmontanensis700 RNA with (lane 5) and without
reverse transcriptase (lane 6).
doi:10.1371/journal.pone.0008965.g004
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Transposon-based transformation of R. montanensis follows that
of R. prowazekii [37,38,41] and R. monacensis [39,30], albeit without
the high efficiency typical of plasmid transformation of bacteria.
The long-standing barriers to transformation of rickettsiae [33]
have been overcome, allowing evaluation of transcriptional
regulatory elements, selectable markers and reporter genes for
use in further development of rickettsial transformation technol-
ogies. The currently available transformant rickettsiae expressing
fluorescent reporter genes are of immediate practical value by
allowing visualization of living rickettsiae in unfixed host tissues as
in the case of GFP-fluorescent R. monacensis in Ixodes scapularis [47].
The Rmontanensis700 transformant can be used to enhance the
R. montanensis in D. variabilis model system [30,31,32].
Earlier efforts to transform rickettsiae relied on recombination
of selectable marker or GFP reporter genes unaccompanied by a
promoter into chromosomal loci under regulation of an active
rickettsial promoter [48,49,50], or recombination of a reporter
gene under regulation of a cloned E. coli promoter [51]. The
transformant rickettsiae had low level and/or unstable expression
of the foreign gene. Although the present transposon strategy using
cloned rickettsial promoters to regulate gene expression has been
much more successful, only four promoters have been used to
date. The R. prowazekii rpsL, the R. rickettsii ompA and the Borrelia flg
promoters have been used to express a rifampin resistance factor,
GFPuv and the Himar1 transposase, respectively, in R. prowazekii,
but without evaluation of mRNA transcription or protein
expression [37,41]. The ompA promoter was used to express the
GFPuv and CAT genes in a R. monacensis transposon-mediated
transformant, Rmona658 [39]. Northern blots showed that single
mRNAs of predicted length were expressed from both genes and
the expected GFPuv protein was observed on Western immuno-
blots. A second transformant (Rmona601) correctly expressed
CAT mRNA under regulation of the ompA promoter but the
DsRed2 gene, under regulation of the ompB promoter, was
expressed as full-length and half-length mRNAs that were not
translated, probably due to extreme GC-rich codon bias versus the
AT-rich codon bias of rickettsiae [39]. In this report, we have
shown that the ompB promoter-driven CAT and GFPuv genes in
Rmontanensis700 were both expressed as two mRNA species that
were larger and smaller than predicted. The larger CAT mRNA
transcript was much more abundant than the smaller transcript
but the larger and smaller GFPuv transcripts were of approxi-
mately equivalent abundance (Fig. 5). Western immunoblots
nevertheless showed that Rmontanensis700 protein extracts
contained a GFPuv protein of the expected mass that co-migrated
with GFPuv protein expressed by E. coli transformed with the
pMOD700 transposon [Fig. 6]. The low GFPuv fluorescence
intensity of Rmontanensis700 rickettsiae, as compared to that of
Rmona658 rickettsiae, was therefore not due to expression of a
compromised GFPuv protein. While we did not compare CAT
activity in the transformant rickettsiae, the 3-fold greater period of
time required to obtain the Rmontanensis700 line under a 2-fold
lower concentration of CHL than that required to obtain the
Rmona658 line in the same host cell line [39] suggested a
relatively lower level of CAT activity in Rmontanensis700.
With the exception of the difference in promoters, the
pMOD658 and pMOD700 transposons used to transform R.
monacensis and R. montanensis, respectively, were essentially identical.
In both transposons, the GFPuv and CAT expression cassettes
were in tandem head to tail orientation, each with an independent
ompA transcription terminator. In the Rmona601 transformant,
the predicted CAT mRNA was expressed from pMOD601 in
which the ompACAT and ompBDsRed2 expression cassettes were
in opposed head to tail orientation with a single shared ompA
terminator [39]. The ompB promoters in Rmona601 and
Rmontanensis700 drove expression of aberrant DsRed2, GFPuv
and CAT mRNAs regardless of the orientations of the expression
cassettes or the presence of independent or single shared
transcription terminators. In contrast, the ompA promoter drove
expression of the predicted GFPuv and CAT mRNAs from both
tandem or opposed head-to-tail expression cassettes within the
same transposon.
The R. rickettsii ompA and ompB promoter transcription start sites
and their relative activities were originally characterized on the
basis of primer extension and Northern blot analyses of RNA
extracts from E. coli transformed with a promoter assay vector
containing a CAT reporter gene [45]. Steady state CAT mRNA
levels and CAT protein levels in E. coli containing the ompB
promoter version of the vector were approximately 2-fold and 28-
fold higher, respectively than those of E. coli containing the ompA
promoter version of the vector. The results implied significant
differences in mRNA stability and/or efficiency of translation,
possibly influenced by sequences present in the approximately 120
and 20 nucleotide 59 untranslated regions of the ompB and ompA
promoter-regulated mRNAs, respectively. In R. rickettsii, the
relative levels of OmpB protein were approximately 9-fold higher
Figure 5. Detection of GFPuv and CAT mRNAs in Rmontanen-
sis700 RNA extracts by Northern blotting. (A) Rickettsial RNA
extracts electrophoresed on 1% agarose formaldehyde gels stained
with EtBr. Lanes 1 and 4: 0.5 to 4.0 kb RNA marker ladder with sizes
indicated at left. Lanes 2 and 5: untransformed R. montanensis RNA
(5 mg). Lanes 3 and 6: Rmontanensis700 RNA (5 mg). (B) Northern blots
of gels shown in panel A. Lanes 1–3 were hybridized with a GFPuv gene
probe and lanes 4–6 with a CAT gene probe.
doi:10.1371/journal.pone.0008965.g005
Figure 6. Western immunoblot of R. montanensis and E. coli
protein extracts. Lanes 1 and 5: SeeBlue Plus 2 markers (Invitrogen,
Carlsbad, CA) with sizes in kilodaltons indicated at left. Lane 2: E. coli
transformed with pMOD700 plasmid. Lane 3: Rmontanensis700
transformed with the pMOD700 transposon. Lane 4: Untransformed R.
montanensis. Ten mg protein were loaded per lane and the blot was
probed with anti-GFP antibody.
doi:10.1371/journal.pone.0008965.g006
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indicated that ompB mRNA half-life was several-fold longer than
that of ompA mRNA. Those results suggested to us that the R.
rickettsii ompB promoter would drive higher gene expression than
the ompA promoter in transformant rickettsiae. Our results have
indicated the opposite.
We have demonstrated the apparent practical superiority of the
R. rickettsii ompA promoter over the ompB promoter as a regulator of
foreign gene expression in two species of transformant rickettsiae.
However, it is not clear whether that was due to species-specific
differences in promoter activity and transcript fidelity without the
influence of transposon integration site effects. Accurate evaluation
of promoters for expression of foreign genes in transformant
rickettsiae awaits availability of a rickettsial transformation vector
that allows direct comparison of gene expression constructs differing
only in promoters and free of possible chromosome integration
effects. The recently discovered plasmids of the Rickettsia [40,52,53]
may provide a basis for development of such a vector.
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